Correlation Between Milestone Pharmaceuticals and Immunome
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Immunome, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Immunome.
Diversification Opportunities for Milestone Pharmaceuticals and Immunome
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Milestone and Immunome is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Immunome go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Immunome
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 0.93 times more return on investment than Immunome. However, Milestone Pharmaceuticals is 1.07 times less risky than Immunome. It trades about 0.28 of its potential returns per unit of risk. Immunome is currently generating about -0.18 per unit of risk. If you would invest 144.00 in Milestone Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 40.00 from holding Milestone Pharmaceuticals or generate 27.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Immunome
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Immunome |
Milestone Pharmaceuticals and Immunome Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Immunome
The main advantage of trading using opposite Milestone Pharmaceuticals and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.The idea behind Milestone Pharmaceuticals and Immunome pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Immunome vs. Eliem Therapeutics | Immunome vs. HCW Biologics | Immunome vs. Scpharmaceuticals | Immunome vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |